Bayer proposes $7.25 billion plan to settle Roundup cancer cases

Reuters Videos

Wed, February 18, 2026 at 1:33 PM GMT+9

In this video:

BAYRY

+6.19%

STORY: Bayer said Tuesday its Monsanto unit had reached an agreement worth as much as $7.25 billion to resolve current and future lawsuits claiming its Roundup weedkiller caused cancer. The company is facing claims from approximately 65,000 plaintiffs in the U.S. They say they developed non-Hodgkin lymphoma and other forms of cancer after using the weedkiller.Bayer has said studies show Roundup and its active ingredient, glyphosate, are safe for human use.The deal covers the bulk of the lawsuits, but requires a judge’s approval and a minimum number of plaintiffs to opt in.It does not require Bayer to admit liability or wrongdoing, and allows it to back out if too many plaintiffs decline to participate.:: FileFollowing the announcement, Bayer shares rose as much as 7.7%.Tuesday’s proposed settlement comes after the U.S. Supreme Court agreed to hear an appeal in a case that Bayer argues will sharply limit its liability in the litigation.The firm is arguing that consumers should not be allowed to sue it under state law for failing to warn that Roundup increases cancer risk.It says this is because the U.S. Environmental Protection Agency has found no such risk and requires no such warning.The German company previously paid about $10 billion to settle most of the Roundup lawsuits that were pending as of 2020.

Terms and Privacy Policy

Privacy Dashboard

More Info